CIK: 1174449 - Address: Pfizer Inc.-Corp. Secretary, 235 East 42Nd St., New York, NY 10017
37 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret111412-11362
S%wins57366443433146

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

3/3/20 12:49
2/28/20
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsCangialosi Loretta VNYOSVP,ContM.d75127.3702728125D
2/28/20 19:15
2/26/20
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsCangialosi Loretta VNYOSVP,ContM.d83634.5902426116D
3/1/19 19:29
2/27/19
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsCangialosi Loretta VNYOSVP,ContM.d82932.2302630111D
8/3/18 15:36
8/1/18
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsCangialosi Loretta VNYOSVP,ContS-1,07740.160-27-2486D
3/2/18 15:24
2/28/18
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsCangialosi Loretta VNYOSVP,ContM.d90427.3703342112D
2/27/18 19:30
2/24/18
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsCangialosi Loretta VNYOSVP,ContM.d53518.9002839101D
2/27/17 18:10
2/23/17
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsCangialosi Loretta VNYOSVP,ContM.d76621.0333367784D6160106752010
5/26/16 10:07
5/24/16
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsCangialosi Loretta VNYOSVP,ContM.d2,22525.87338685187D2441213633202-12-7
5/26/16 10:07
5/24/16
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsCangialosi Loretta VNYOSVP,ContS.d-2,92133.9733-86-32187D2441213633202-12-7
2/26/16 15:05
2/24/16
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsCangialosi Loretta VNYOSVP,ContM.d64618.90333421194D3-9-1-12532-1-2-3131616
8/3/15 07:24
7/30/15
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsCangialosi Loretta VNYOSVP,ContS-88135.6533-25-12175D312917764320-2-10-3-157
2/27/15 18:27
2/25/15
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsCangialosi Loretta VNYOSVP,ContM.d58317.69333320198D3712201575011011-4-9
2/17/15 17:50
2/13/15
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsCangialosi Loretta VNYOSVP,ContM.d2,72526.2033104128185D37132315127810-1-1-14-11
2/17/15 17:50
2/13/15
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsCangialosi Loretta VNYOSVP,ContS.d-3,61234.7333-104-36185D37132315127810-1-1-14-11
1/5/15 17:17
12/31/14
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsCangialosi Loretta VNYOSVP,ContM.d58418.19333221185D296493-1-201531286
3/5/14 17:37
3/3/14
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsCangialosi Loretta VNYOSVP,ContM.d1,97826.20337678172M66221846341-1-1-1-9-910
3/5/14 17:37
3/3/14
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsCangialosi Loretta VNYOSVP,ContS.dm-3,29932.0533-103-37172M66221846341-1-1-1-9-910
2/28/14 16:52
2/26/14
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsCangialosi Loretta VNYOSVP,ContM.d71612.70335638206D6321171451101-1-7-611
11/4/13 15:59
11/1/13
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsCangialosi Loretta VNYOSVP,ContS.d-31231.2033-10-5181D743110786200112-40
8/1/13 17:39
7/31/13
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsCangialosi Loretta VNYOSVP,ContS.d-43529.6333-15-7190D642883120011-3772
3/4/13 18:49
2/28/13
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsCangialosi Loretta VNYOSVP,ContM.d1,00722.55334528202D5434171232-11126-1320
3/5/12 17:12
3/5/12
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsCangialosi Loretta VNYOSVP,ContS-53221.5233-25-12181D3413158-1201-10521336
8/4/10 15:49
8/4/10
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsCangialosi Loretta VNYOSVP,ContS-20716.2733-13-7182D-26-13-491012823192016
8/18/09 17:00
8/18/09
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsCangialosi Loretta VNYOSVP,ContS-32015.9933-20-10173D-24-161461001025311136
5/11/09 17:13
5/11/09
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsCangialosi Loretta VNYOSVP,ContS-30514.2433-21-10191D-40-23-12-24782660142225
5/1/07 16:41
4/27/07
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsCangialosi Loretta VNYOVP,ContrM.d14818.353386150D511-2342-21034-10-7-20
5/1/07 16:41
4/27/07
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsCangialosi Loretta VNYOVP,ContrS.d-95026.5333-36-19150D511-2342-21034-10-7-20
11/13/06 10:09
11/8/06
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsCangialosi Loretta VNYOVP,ContrM.d10018.353354160D1205-1-8-6-2-516-259-4
5/2/06 17:02
5/2/06
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsCangialosi Loretta VNYOVP,ContrS.d-26225.1333-10-6156B01-541010
3/7/06 13:12
3/6/06
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsCangialosi Loretta VNYOVP,ContrM.d15412.4233128165B10-3-7101
3/7/06 13:12
3/6/06
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsCangialosi Loretta VNYOVP,ContrS.d-11526.1733-4-3165B10-3-7101
5/11/05 10:46
5/10/05
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsCangialosi Loretta VNYOVP,ContrM.d88.173311125D-12-21-19532-1130-3-18-6
5/11/05 10:46
5/10/05
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsCangialosi Loretta VNYOVP,ContrS.d-2727.7833-1-1125D-12-21-19532-1130-3-18-6
3/15/05 15:10
3/14/05
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsCangialosi Loretta VNYOVP,ContrM.d888.1733119125D-6-23-16-11100-1-1-33611
11/17/04 13:38
11/16/04
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsCangialosi Loretta VNYOVP,ContrM.d128.17332285D-14-18-22-14-12-5-512-26-86-17
2/20/04 11:34
2/19/04
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsCangialosi Loretta VNYOVP,ContrM.d125.71332453D-531201022-2000-9-5-15-31
8/28/03 09:06
8/27/03
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsCangialosi Loretta VNYOVP,ContrM.d215.71334851D-24-83-4-8-9-51022132411

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact